In the realm of biochemical research and peptide science, few compounds have garnered as much attention as the bicyclic molecule known as depsipeptide. Often referred to in scientific literature by it Molecular basis for depsipeptide HDAC inhibitor s designation Enhancement of HDAC-inhibitory Activity by Reduction of FK228.FK228 is a bicyclic depsipeptidethat is structurally distinct from other HDAC inhibitors.Read more FK228, also known as depsipeptide, this compound represents a fascinating intersection of natural product chemistry and enzymatic regulation. As someone deeply interested in the structural nuances of peptide-based research, I have spent considerable time reviewing the molecular characteristics of this unique agent.
Understanding the Structural Complexity
At its core, FK228 is a bicyclic depsipeptide that stands apart from linear synthetic alternatives. The molecule features a complex 16-membered cyclic depsipeptide structure, which is integral to its biological behavior. When analyzing the depsipeptide HDAC landscape, it is important to rec Depsipeptide, an HDAC inhibitor, recruits p300 and p21 through p53 acetylation and has demonstrated therapeutic potency in lung cancer [27, 28]. On the other Read more ognize that this molecule acts as a natural prodrug. It requires intracellular reduction to become active, a mechanism that highlights its high degree of specificity.
Research consistently demonstrates that depsipeptide is a histone deacetylase inhibitor molecule of exceptional potency. Unlike broader age The cyclic depsipeptide FK228is the only natural product histone deacetylase (HDAC) inhibitorthat has advanced to clinical trials as an anticancer agent.Read more nts, it is a potent and selective inhibitor of HDAC1 and HDAC2, which are crucial enzymes involved in the regulation of gene expression through chromatin remodeling.
Mechanism and Potency
The efficiency of this compound is well-documented. It is highly efficient in inhibiting the activity of HDACs, often functioning at nanomolar concentrations. My own observations of the available data suggest that depsipeptide has nanomolar inhibitory HDAC activity, which makes it a frequent subject for those studying the modulation of histone acetylation.
Furthermore, the histone deacetylase inhibitor (HDACi) profile of this compound is distinct. It is the only natural product histone deacetylase (HDAC) inhibitor that has undergone extensive evaluation in advanced research settings. Because depsipeptide, an HDAC inhibitor, recruits p300 and p21 via p53 acetylation, it offers a sophisticated pathway for studying cell cycle arrest and protein signaling.
Key Characteristics at a Glance
When considering the utili Therefore, development of anHDAC/PI3K dual inhibitor is reasonably attractive. Romidepsin (FK228,depsipeptide) is a potentHDACinhibitor. We have previously Read more ty of this compound in labora Romidepsin (FK228 ,Depsipeptide).HDACinhibitor. Romidepsin strongly inhibits HDAC1 and HDAC2 with IC5N/A of 1.6 nM and 3.9 nM Read more tory settings, several factors define its profile:
* Selectivity: It is known to inhibit class I HDACs with high affinity.
* Potency: It is widely considered among the most potent histone deacetylase (HDAC) inhibitors currently documented in biochemical databases.
* Dual Function: Beyond simple deacetylation, depsipeptide not only modulates histone deacetylation but also influences non-histone proteins, expanding its utility in molecular studies. by PA Konstantinopoulos·2006·Cited by 96—Depsipeptide has nanomolar inhibitory HDAC activitywhich is reversible. The macrocyclic peptide portion of the inhibitor binds with high Read more
Research Context and Safety
It is important to note that histone deacetylase inhibitors (HDACi) are a broad field of study. While many compounds are being screened, the specific depsipeptide molecule stands out due to its origin as a bacterial natural product. In early investigative studies, it was found to be safe in humans during initial trials, though my focus remains strictly on the biochemical and structural properties of the peptide itself.
The exploration of HDAC2 inhibitors are members of a new class of agents that continue to provide insight into how cells manage genetic expression. By focusing on depsipeptide, researchers can better understand the delicate balance of the epig by SB Khan·2004·Cited by 139—Depsipeptide, a new member of the HDAC inhibitors,was found to be safe in humansand has been shown to induce apoptosis in various cancers. In order to Read more enome. Whether you are looking at depsipeptide hdacinhibitors or broader depsipeptide hdacdrugs, the consensus remains that this compound is a foundational tool for those exploring the frontiers of peptide-based enzymatic modulation.
Final Thoughts
The study of HDAC (Histone Deacetylase) regulation remains a pillar of modern molecular biology. The Histone Deacetylase Inhibitor Depsipeptide remains a gold standard for researchers because it is potent and selective inhibitor of histone deacetylases (HDACs). As a novel inhibitor of class I HDAC, its unique bicyclic structure ensures it remains a subject of intense scientific scrutiny and a vital component in the library of any serious peptide enthusiast.